Zika is spread mostly by the bite of an infected Aedes species mosquito. These mosquitoes bite during the day and night. There is no specific medicine or vaccine for Zika virus. Several investigational vaccines are under development, including early human clinical trials.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/413
Major players operating in the global zika vaccines market include, Biken Inc., Bharat Biotech International Pvt. Ltd., Cerus Corporation, GlaxoSmithKline plc, GeneOne Life Science, Inovio Pharmaceuticals, Immunovaccine Inc., NewLink Genetics Corp., and Sanofi S.A.
Key Market Drivers:
Approval and launch of new products is expected to propel growth of the global zika vaccines market over the forecast period. For instance, in August 2019, Moderna, Inc. received the U.S. Food and Drug Administration’s Fast Track designation for its investigational Zika vaccine (mRNA-1893) currently being evaluated in a Phase 1 study for the prevention of Zika virus infection in healthy adults.
Moreover, R&D in zika treatment is also expected to aid in growth of the global zika vaccines market. For instance, in November 2021, a team of researchers at the Institute of Medical Sciences in Banaras Hindu University, India, reported an important finding on Zika virus pathogenesis in a study published in the journal ‘Molecular Neurobiology’.
Covid-19 Impact Analysis
R&D for effective vaccines against Covid-19 have also boosted development towards zika vaccine. For instance, in November 2021, Emergex received approval to conduct initial human trials in Lausanne, of its experimental Covid-19 vaccine, from the Swiss drugs regulator. The company also wants to deploy its T-cell vaccines against influenza, Zika, Ebola and other infections.
Major players operating in the global zika vaccines market are focused on R&D to expand their product portfolio. For instance, in June 2021, ModernaTX, Inc., a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, initiated a study to evaluate the safety, tolerability and reactogenicity of 2 dose levels of mRNA 1893 Zika vaccine in comparison to a placebo control in healthy participants who are flavivirus-seronegative.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/413
Reasons to Purchase this Report
• Current and future of global Zika Vaccines Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/413
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Zika Vaccines Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Zika Vaccines Industry Impact
Chapter 2 Global Zika Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Zika Vaccines (Volume and Value) by Type
2.3 Global Zika Vaccines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Zika Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Zika Vaccines Market Analysis
Chapter 6 East Asia Zika Vaccines Market Analysis
Chapter 7 Europe Zika Vaccines Market Analysis
Chapter 8 South Asia Zika Vaccines Market Analysis
Chapter 9 Southeast Asia Zika Vaccines Market Analysis
Chapter 10 Middle East Zika Vaccines Market Analysis
Chapter 11 Africa Zika Vaccines Market Analysis
Chapter 12 Oceania Zika Vaccines Market Analysis
Chapter 13 South America Zika Vaccines Market Analysis
Chapter 14 Company Profiles and Key Figures in Zika Vaccines Business
Chapter 15 Global Zika Vaccines Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027